Federal hearing for Luigi Mangione scheduled amid speculation of plea deal
A federal hearing for Luigi Mangione, charged in the killing of UnitedHealthcare CEO Brian Thompson, was set for Friday, prompting speculation about a possible guilty plea and raising questions about its impact on his separate state trial.
A Manhattan federal judge scheduled a hearing for Luigi Mangione on Friday morning, a move that has led observers to wonder whether he may enter a guilty plea in the case involving the 2024 killing of UnitedHealthcare CEO Brian Thompson. Mangione faces two federal stalking counts and, in a parallel New York state proceeding, murder and weapons charges; he has pleaded not guilty in both jurisdictions, and each case carries a potential life sentence.
The hearing was arranged after Mangione’s defense and prosecutors jointly requested a conference, submitting a brief letter that simply noted the court’s availability on August 14 at 11:00 a.m. The timing of the request, coming shortly after Mangione’s final pre-trial conference in the state case scheduled for trial on September 8, has fueled speculation that a plea agreement may be under discussion.
If Mangione were to plead guilty in the federal matter, it could affect the state prosecution, as New York law generally bars double jeopardy but includes exceptions that may apply.
In the state case, Judge Gregory Carro ordered an anonymous jury, citing concerns about juror safety and the risk of intimidation stemming from extensive pre-trial publicity. > "The pre-trial publicity surrounding this case presents a significant risk of juror harassment and intimidation that warrants reasonable protective measures to ensure the integrity of these proceedings, minimize obstacles to jury selection and protect juror safety," prosecutors wrote in a July 22 letter.
The court found documented threats and harassment directed at individuals connected to the case, concluding that revealing jurors’ identities would increase the risk of improper influence.